Stomach ultrasound study for diabetes and obesity
Treatments studied
Part of Digestive system, Hormones & metabolism clinical trials.
This study uses ultrasound to see how GLP-1 RA medications (like Ozempic) affect the stomach in people with type 2 diabetes and obesity. It may help doctors better understand how these medicines work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a body mass index (BMI) over 35.
- You have type 2 diabetes.
- You are either currently taking a GLP-1 RA medication (like Ozempic or Wegovy) or you are not taking one.
- You do not have a condition called gastroparesis (slow stomach emptying).
- You have not had gastric bypass or any other stomach surgery.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how GLP-1 medications (like Ozempic or Wegovy) affect the movement of food through your stomach and intestines. You may join if you are starting or recently stopped one of these medications and have type 2 diabetes or obesity.
This study looks at what happens when people taking a GLP-1 medication (like Ozempic) either stop or continue it after weight loss surgery. The goal is to learn whether staying on the medicine helps with long-term weight control.
This trial tests a medicine called a GLP-1 receptor agonist (like Ozempic) to see if it can help people with very early type 1 diabetes (stage 1) keep their insulin-making cells working longer. You may be a good fit if you have stage 1 type 1 diabetes and haven't needed insulin yet.
This trial uses a stomach ultrasound (called gastric POCUS) to check if your stomach is empty before surgery. It is for patients taking GLP-1 medications (like Ozempic, Wegovy, or similar) to help make sure it is safe to proceed with anesthesia.
This study uses an ultrasound to look at how full your stomach is after taking GLP-1 medications for diabetes or weight loss. It will help doctors understand if current fasting guidelines are safe before surgery or a colonoscopy.
This trial uses an ultrasound (a safe, painless scan using sound waves) on the stomach before and after bariatric surgery to better understand how the stomach changes. It may help improve care for future patients.
Hear when a new Delayed Gastric Emptying trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.